• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大分割放疗的原理。

Rationale for hypofractionation.

作者信息

Hennequin C, Guillerm S, Quero L

机构信息

Radiation oncology department, hôpital Saint-Louis, AP-HP, Paris, France.

Radiation oncology department, hôpital Saint-Louis, AP-HP, Paris, France.

出版信息

Cancer Radiother. 2019 Oct;23(6-7):500-502. doi: 10.1016/j.canrad.2019.07.156. Epub 2019 Aug 20.

DOI:10.1016/j.canrad.2019.07.156
PMID:31444076
Abstract

Fractionation was established more than fifty years ago as the best way to obtain a differential effect between tumors and normal tissues. However, new technologies allowed today to spare critical organs from the radiation fields. And so protracted courses of irradiation are no longer required. Hypofractionation have clear practical advantages over classical fractionation: it saves the patient time; it saves money for public health system; it reduces pressure on radiotherapy units. In several localization, it has proved to be as efficient as classical fractionation without increasing late effects. In prostate cancer, some radiobiological considerations argue in favor of a better efficiency, but clinical trials did not demonstrated differences in biological control. In conclusion, for all diseases where hypofractionation was demonstrated efficient, it must be fully implemented. Invoice procedures must be adapted to maintain a sufficient level of reimbursement of radiotherapy centers.

摘要

五十多年前就确立了分次放疗作为在肿瘤与正常组织之间获得差异效应的最佳方法。然而,如今的新技术能够使关键器官免受辐射野的影响。因此,不再需要长时间的照射疗程。与传统分次放疗相比,大分割放疗具有明显的实际优势:它节省了患者的时间;为公共卫生系统节省了资金;减轻了放疗单位的压力。在多个部位,已证明其与传统分次放疗一样有效,且不会增加晚期效应。在前列腺癌中,一些放射生物学考量支持其具有更高的效率,但临床试验并未证明在生物学控制方面存在差异。总之,对于所有已证明大分割放疗有效的疾病,都必须全面实施。发票程序必须进行调整,以维持放疗中心足够的报销水平。

相似文献

1
Rationale for hypofractionation.大分割放疗的原理。
Cancer Radiother. 2019 Oct;23(6-7):500-502. doi: 10.1016/j.canrad.2019.07.156. Epub 2019 Aug 20.
2
Optimized Hypofractionation Can Markedly Improve Tumor Control and Decrease Late Effects for Head and Neck Cancer.优化的低分割放疗可以显著提高头颈部肿瘤的控制率并降低晚期效应。
Int J Radiat Oncol Biol Phys. 2019 Jun 1;104(2):272-278. doi: 10.1016/j.ijrobp.2019.02.025. Epub 2019 Feb 16.
3
[Moderate or extreme hypofractionation and localized prostate cancer: The times are changing].[适度或极度超分割与局限性前列腺癌:时代在变]
Cancer Radiother. 2019 Oct;23(6-7):503-509. doi: 10.1016/j.canrad.2019.07.139. Epub 2019 Aug 27.
4
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial.对于前列腺癌患者的低分割与常规分割放疗(HYPRO):一项随机非劣效性 3 期试验的急性毒性结果。
Lancet Oncol. 2015 Mar;16(3):274-83. doi: 10.1016/S1470-2045(14)70482-6. Epub 2015 Feb 3.
5
Modern hypofractionation schedules for tangential whole breast irradiation decrease the fraction size-corrected dose to the heart.现代切线野全乳腺照射的适形分割方案降低了心脏的分次剂量校正值。
Clin Oncol (R Coll Radiol). 2013 Mar;25(3):147-52. doi: 10.1016/j.clon.2012.07.012. Epub 2012 Aug 19.
6
[Practice evolution of hypofractionation in breast radiation therapy and medical impact].[乳腺癌放疗中分割放疗的实践演变及其医学影响]
Cancer Radiother. 2016 Jun;20(4):299-303. doi: 10.1016/j.canrad.2016.04.005. Epub 2016 Jun 23.
7
Are We Now Able to Define Guidelines for Moderate Hypofractionation in Prostate Cancer Radiation Therapy?我们现在是否能够确定前列腺癌放射治疗中适度低分割放疗的指南?
Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):871-873. doi: 10.1016/j.ijrobp.2017.12.274.
8
Hypofractionated radiotherapy for localized prostate cancer.局限性前列腺癌的大分割放疗
Strahlenther Onkol. 2017 Jan;193(1):1-12. doi: 10.1007/s00066-016-1041-5. Epub 2016 Sep 14.
9
Radiobiological rationale and clinical implications of hypofractionated radiation therapy.大分割放射治疗的放射生物学原理及临床意义
Cancer Radiother. 2011 Jun;15(3):221-9. doi: 10.1016/j.canrad.2010.12.007. Epub 2011 Apr 21.
10
Breast, Prostate, and Rectal Cancer: Should 5-5-5 Be a New Standard of Care?乳腺癌、前列腺癌和直肠癌:5-5-5应成为新的护理标准吗?
Int J Radiat Oncol Biol Phys. 2020 Oct 1;108(2):390-393. doi: 10.1016/j.ijrobp.2020.06.049.

引用本文的文献

1
New Approaches in Breast Cancer Radiotherapy.乳腺癌放射治疗的新方法。
Eur J Breast Health. 2023 Dec 27;20(1):1-7. doi: 10.4274/ejbh.galenos.2023.2023-11-4. eCollection 2024 Jan.
2
Comparison of peripheral leukocyte parameters in patients receiving conventionally and hypofractionated radiotherapy schemes for the treatment of newly diagnosed glioblastoma.比较新诊断的胶质母细胞瘤患者接受常规和低分割放疗方案治疗时的外周白细胞参数。
Front Immunol. 2023 Oct 26;14:1284118. doi: 10.3389/fimmu.2023.1284118. eCollection 2023.
3
Hypofractionation: less is more?
大分割放疗:少即是多?
Oncotarget. 2021 Aug 17;12(17):1729-1733. doi: 10.18632/oncotarget.28023.
4
Ten Daily Fractions for Whole Breast Cancer Irradiation: Long Term Results.每日 10 次分割全乳照射:长期结果。
In Vivo. 2021 Sep-Oct;35(5):2875-2880. doi: 10.21873/invivo.12576.